Clinical updates, including trial initiations, enrollment status and data readouts and publications: Curevac, Cyteir, Denali, Diurnal, Dompé, Merck & Co., Opiant, Phathom, Regenxbio, Sanofi, Scynexis, Sumitomo Dainippon, Vicore.